DocDollars

Biotissue Holdings Inc.

FL · United States · Reporting entity ID 100000011111

Total reported 2019–2025
$18.3M
#343 of 2,960 reporting companies — 0% of all reported industry payments
$8.53M in general payments across 76,082 records, plus $9.74M in research funding across 3,909 records.

How it breaks down

General payments $8,533,611
Research funding $9,741,279

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Biotissue Holdings Inc. reported $18.3M to US doctors and teaching hospitals from 2019 to 2025, ranking #343 of 2,960 reporting companies. 53% of that was research funding and 47% general payments such as consulting, speaking, food and travel. 76,082 general payment records and 3,909 research records were filed.

Common questions about Biotissue Holdings Inc.

How much has Biotissue Holdings Inc. paid US doctors?

Biotissue Holdings Inc. reported $18,274,891 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,533,611 in general payments, $9,741,279 in research funding.

How does Biotissue Holdings Inc. rank among drug and device companies?

It ranks #343 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Biotissue Holdings Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.